10 employees
Apsara Therapeutics develops antibody therapies for the treatment of neuromyelitis optica.
2012
$750K
from 2 investors over 2 rounds
Apsara TV raised $750K on March 31, 2014
Investors: Mercury Fund
Apsara TV raised $250K on February 27, 2014